Skip to content
10-Q

Quarterly Report

IRIS BIOTECHNOLOGIES INC

0001554795-13-000678

← back to feed
Filed
Nov 12, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Nov 12, 2013 13.45M sh
Capex Q3 2013 · Sep 30, 2013 $228.37K
Operating Cash Flow Q3 2013 · Sep 30, 2013 −$3.46M
Operating Cash Flow Q3 2013 · Sep 30, 2012 −$202.69K
Stockholders Equity Q3 2013 · Sep 30, 2013 −$190.92K
Stockholders Equity Q3 2013 · Dec 31, 2012 −$119.08K
Current Liabilities Q3 2013 · Sep 30, 2013 $182.87K
Current Liabilities Q3 2013 · Dec 31, 2012 $96.8K
Total Liabilities Q3 2013 · Sep 30, 2013 $198.87K
Total Liabilities Q3 2013 · Dec 31, 2012 $143.8K
Current Assets Q3 2013 · Sep 30, 2013 $3.04K
Current Assets Q3 2013 · Dec 31, 2012 $15.76K
Total Assets Q3 2013 · Sep 30, 2013 $7.95K
Total Assets Q3 2013 · Dec 31, 2012 $24.72K
Eps Basic Q3 2013 · Sep 30, 2013 −$0.01
Eps Basic Q3 2013 · Sep 30, 2013 −$0.02
Eps Basic Q3 2013 · Sep 30, 2012 −$0.01
Eps Basic Q3 2013 · Sep 30, 2012 −$0.03
Sga Expense Q3 2013 · Sep 30, 2013 $5.4M
Sga Expense Q3 2013 · Sep 30, 2012 $102.39K
Sga Expense Q3 2013 · Sep 30, 2012 $333.93K
Rd Expense Q3 2013 · Sep 30, 2013 $2.23M
Rd Expense Q3 2013 · Sep 30, 2012 $53.11K
Rd Expense Q3 2013 · Sep 30, 2012 $84.12K
Net Income Q3 2013 · Sep 30, 2013 −$9.49M
Net Income Q3 2013 · Sep 30, 2012 −$159.58K
Net Income Q3 2013 · Sep 30, 2012 −$430.5K
Cash And Equivalents Q3 2013 · Sep 30, 2012 $6.04K
Cash And Equivalents Q3 2013 · Dec 31, 2011 $43.73K